Profitable Telemedicine Company Investment Opportunity in Manlius, United States
Established | 1-5 year(s) |
Employees | 5 - 10 |
Legal Entity | Limited Liability Company (LLC) |
Reported Sales | USD 5.9 thousand |
Run Rate Sales | USD 5.9 thousand |
EBITDA Margin | 35 % |
Industries | Telemedicine |
Locations | Manlius |
Local Time | 10:21 AM America / Nipigon |
Listed By | Business Owner / Director |
Status | Active |
- We are now seeking seed funds for the further development and marketing of our skin cancer patients lesions large vision AI model in exchange for a stake in our company.
- This would be an initial Minimum Viable Product (MVP) which later will be incorporated into our full skin cancer patient blockchain.
- Funds obtained will also be used to further test, validate, and expand the model while increasing the number of patients tested by the model. Along with this, we also use the funds to market the model to research investigators, patients, dermatologists, oncologist, pathologist, and other healthcare professionals.
- With a dedicated team of 6 employees, the company is agile and focused on delivering cutting-edge diagnostics and digital health products tailored for individuals battling skin cancer.
- The company addresses a critical need within healthcare by concentrating on skin cancer, leveraging digital technologies to improve patient engagement and accessibility to care.
- $86,000 from founder to company.